Sponsor study identifier
interventional
3
1 country
1
Study Start
April 1, 2016
Actual (reported)Primary Completion
September 2020
Actual (reported)Study Completion
September 2020
Actual (reported)The investigators will apply xenon-129 (129Xe) and non-contrast enhanced magnetic resonance imaging (MRI) acquisition and analysis methods in 50 subjects aged between 20 and 29 years born pre-term (with and without a diagnosis of bronchopulmonary dysplasia \[BPD\]) and at term to characterize and probe the relationship between lung structure and function using imaging.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 19, 2016
Actual (reported)March 30, 2016
Actual (reported)April 1, 2016
Actual (reported)September 2020
Actual (reported)September 2020
Actual (reported)Number of patients with MRI-derived tissue signal intensity less than normal for age-matched individuals without BPD
This will be measured using non-contrast enhanced MRI methods (ultra-short echo time MRI) and hyperpolarized noble gas MRI methods. Mean whole lung signal intensity measurements will be quantified after the UTE MRI acquisition. Ventilation defect percent and apparent diffusion coefficients will be determined after noble gas MR acquisition.
Baseline
Forced Expiratory Volume in 1 s (FEV1) measured using spirometry
Baseline
Number of patients with abnormal Pulmonary Function measurement of surface-to volume ratio for gas exchange
Baseline
All enrolled preterm adults will undergo non-contrast enhanced MRI (using ultra-short echo time methods), hyperpolarized noble gas MRI (using hyperpolarized xenon-129), x-ray computed tomography (CT), pulmonary function tests, and questionnaires in a single visit.
Hyperpolarized Xenon-129. Noble gas magnetic resonance imaging (MRI) has recently emerged as another research approach for the non-invasive measurement of lung structure and function, including conduction of gas through airways and into airspaces. Noble gas MRI provides a complimentary and alternative method for evaluating lung disease and may be superior to CT because it allows simultaneous visualization of both airway and airspace structure and function.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Robarts Research Institute; The University of Western Ontario; London Health Sciences Centre
London, Ontario, N6A 5B7, Canada
Grace Parraga, PhD
Western University, Canada
3 participants (actual enrollment reported by the registry).
First Submitted
March 19, 2016
First Posted
March 30, 2016
Study Start
April 1, 2016
Actual (reported)p16Ink4a in Bronchopulmonary Dysplasia in Children
Contact the study team to confirm eligibility.
Primary Completion
September 2020
Actual (reported)Study Completion
September 2020
Actual (reported)Last Updated
May 12, 2023
Record last verified: 2023-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: